T15615	UBERON:0001911 97 110	mammary gland
T15616	UBERON:0001911 218 231	mammary gland
T15617	UBERON:0000310 248 254	breast
T15618	UBERON:0009567 357 365	in lower
T15619	UBERON:0000029 565 571	is not
T15620	UBERON:0003675 665 666	.
T15621	UBERON:0000970 751 758	of mice
T15622	UBERON:0004363 983 1003	characterize mammary
T15623	UBERON:0004044 1158 1164	in the
T15624	UBERON:0003675 1287 1288	.
T15625	UBERON:0010384 1396 1413	lactation failure
T15626	UBERON:0010737 1627 1635	SirT1ko/
T15627	UBERON:0001791 1766 1770	IGF-
T15628	UBERON:0000310 1776 1783	rescued
T15629	UBERON:0003675 1903 1904	.
T15630	UBERON:0001013 2108 2115	in mice
T15631	UBERON:0008338 2214 2220	of IGF
T15632	UBERON:0002328 2437 2447	of mammary
T15633	UBERON:0001450 2587 2589	,2
T15634	UBERON:0000912 2694 2701	family.
T15635	UBERON:0001911 5604 5617	mammary gland
T15636	UBERON:0000062 5630 5635	organ
T15637	UBERON:0002420 5751 5760	the onset
T15638	UBERON:0000992 5773 5780	ovarian
T15639	UBERON:0011256 5996 6005	estrogen,
T15640	UBERON:0002109 6022 6031	pituitary
T15641	UBERON:3010163 6106 6115	local IGF
T15642	UBERON:0001555 6119 6122	but
T15643	UBERON:0018332 6233 6243	lacking GH
T15644	UBERON:0001791 6255 6258	IGF
T15645	UBERON:0004151 6487 6500	the arborated
T15646	UBERON:0005351 6519 6530	established
T15647	UBERON:0010426 6660 6671	the present
T15648	UBERON:0003037 6690 6693	the
T15649	UBERON:0002534 6830 6849	characterization of
T15650	UBERON:0008574 6871 6881	identified
T15651	UBERON:0018357 7031 7040	estrogen–
T15652	UBERON:0006762 7046 7055	signaling
T15653	UBERON:0006862 7196 7207	and methods
T15654	UBERON:0004529 7228 7237	described
T15655	UBERON:3010432 7409 7420	breeding of
T15656	UBERON:0000104 7432 7436	mice
T15657	UBERON:0004082 7574 7582	SirT1co/
T15658	UBERON:0004103 7594 7599	SirT1
T15659	UBERON:0004082 7716 7724	SirT1co/
T15660	UBERON:0004341 7736 7743	SirT1ko
T15661	UBERON:0001431 7798 7809	were housed
T15662	UBERON:0001790 7822 7823	-
T15663	UBERON:2001053 7944 7948	PCR-
T15664	UBERON:0001496 7972 7975	was
T15665	UBERON:0008823 8192 8213	embryonic fibroblasts
T15666	UBERON:0000976 8221 8225	were
T15667	UBERON:0002393 8307 8318	body weight
T15668	UBERON:0000305 8337 8338	a
T15669	UBERON:0002240 8352 8360	insulin-
T15670	UBERON:0001790 8378 8379	-
T15671	UBERON:0003215 17112 17120	alveolar
T15672	UBERON:0004915 17256 17267	coordinated
T15673	UBERON:0003033 17445 17449	some
T15674	UBERON:0002531 17716 17722	extent
T15675	UBERON:0013731 17909 17917	estrogen
T15676	UBERON:0001273 18258 18261	day
T15677	UBERON:0002257 18405 18413	contrast
T15678	UBERON:0001273 18559 18562	day
T15679	UBERON:0003197 18775 18787	observations
T15680	UBERON:0001450 18919 18920	,
T15681	UBERON:0005095 19187 19193	levels
T15682	UBERON:0002391 19410 19417	mammary
T15683	UBERON:0002531 19658 19662	BrdU
T15684	UBERON:0002061 19863 19868	found
T15685	UBERON:0002531 20110 20114	BrdU
T15686	UBERON:0000025 20296 20301	newly
T15687	UBERON:0000025 20482 20487	newly
T15688	UBERON:0003197 20652 20664	observations
T15689	UBERON:0002391 20981 20988	mammary
T15690	UBERON:0000479 20989 20996	tissues
T15691	UBERON:0004341 21104 21111	SirT1ko
T15692	UBERON:0002543 21111 21112	/
T15693	UBERON:0000104 21245 21249	mice
T15694	UBERON:0013428 21250 21252	on
T15695	UBERON:0002543 21477 21478	/
T15696	UBERON:0001465 21478 21480	ko
T15697	UBERON:0000989 21705 21707	+/
T15698	UBERON:0001465 21707 21709	ko
T15699	UBERON:0001464 21975 21977	in
T15700	UBERON:0003983 21978 21984	parous
T15701	UBERON:0001464 22112 22114	in
T15702	UBERON:0004341 22115 22122	SirT1ko
T15703	UBERON:0003037 22223 22226	the
T15704	UBERON:0004290 22227 22236	defective
T15705	UBERON:0012128 22523 22536	morphogenesis
T15706	UBERON:0001450 22536 22537	,
T15707	UBERON:0000305 22697 22698	a
T15708	UBERON:0000979 22699 22706	deficit
T15709	UBERON:0004341 22809 22816	SirT1ko
T15710	UBERON:0002543 22816 22817	/
T15711	UBERON:0001301 23095 23102	exhibit
T15712	UBERON:0001756 23103 23109	normal
T15713	UBERON:0001681 23218 23225	however
T15714	UBERON:0001450 23225 23226	,
T15715	UBERON:0001954 23412 23421	mammalian
T15716	UBERON:0005052 23422 23427	cells
T15717	UBERON:0002291 23605 23617	desensitizes
T15718	UBERON:0003037 23618 23621	the
T15719	UBERON:0015181 23717 23722	IGFBP
T15720	UBERON:0001790 23722 23723	-
T15721	UBERON:0008207 23884 23893	increased
T15722	UBERON:0001464 23894 23896	in
T15723	UBERON:0004180 24092 24107	mammary tissues
T15724	UBERON:0009856 24266 24269	-κB
T15725	UBERON:0004741 24397 24404	IκBα in
T15726	UBERON:0006206 24623 24642	functional alveolar
T15727	UBERON:0009749 24800 24806	or the
T15728	UBERON:0010148 24929 24940	cells could
T15729	UBERON:0004029 25127 25140	], suggesting
T15730	UBERON:0010516 25337 25348	reversed in
T15731	UBERON:0005371 25516 25532	downregulated as
T15732	UBERON:0001454 25702 25704	-1
T15733	UBERON:0007252 25911 25925	interfere with
T15734	UBERON:0001052 26048 26058	we treated
T15735	UBERON:3010242 26204 26213	levels of
T15736	UBERON:0010538 26329 26342	three SirT1ko
T15737	UBERON:0023999 26495 26505	IκB kinase
T15738	UBERON:0001135 26618 26621	NF-
T15739	UBERON:0001135 26741 26744	NF-
T15740	UBERON:0003684 26938 26965	lipopolysacharide treatment
T15741	UBERON:0001911 27046 27059	mammary gland
T15742	UBERON:0004561 27187 27198	IκBα within
T15743	UBERON:0005353 27381 27392	reduced IGF
T15744	UBERON:0001735 27540 27558	manifested varying
T15745	UBERON:0000119 27803 27808	cell-
T15746	UBERON:0005746 27918 27930	has unveiled
T15747	UBERON:0001708 28122 28136	and attenuates
T15748	UBERON:0001710 28199 28215	manifest partial
T15749	UBERON:0034786 28428 28437	and IGFBP
T15750	UBERON:0000467 28592 28601	system is
T15751	UBERON:0002683 28679 28687	of SirT1
T15752	UBERON:0002012 28906 28910	1 or
T15753	UBERON:0005087 29028 29034	cells,
T15754	UBERON:0006715 29195 29208	Akt signaling
T15755	UBERON:0001091 29391 29397	, Akt1
T15756	UBERON:0001095 29489 29506	display perinatal
T15757	UBERON:0004336 29670 29674	, as
T15758	UBERON:0011234 29878 29900	retardation phenotypes
T15759	UBERON:0000113 30286 30295	adulthood
T15760	UBERON:0004605 31358 31360	40
T15761	UBERON:0001893 31921 31923	or
T15762	2 32784 32785	1
T15763	UBERON:0012283 33033 33049	mammary fat pads
T15764	UBERON:0007213 33217 33241	morphogenesis in SirT1ko
T15765	UBERON:0002240 33425 33435	as well as
T15766	UBERON:0001217 33650 33664	1 signaling in
T15767	UBERON:0003691 33844 33860	, including both
T15768	UBERON:0004709 34121 34140	phases and estrogen
T15769	UBERON:0018286 34387 34403	to primitive fat
T15770	UBERON:0015149 34549 34554	IGF-1
T15771	UBERON:0010058 34909 34920	either IGF-
T15772	UBERON:0002130 35113 35129	the influence of
T15773	UBERON:0013174 35191 35208	not sufficient to
T15774	UBERON:0006013 35446 35463	with pituitary GH
T15775	UBERON:2000693 35793 35803	local IGF-
T15776	UBERON:0006762 35961 35973	-1 signaling
T15777	UBERON:0003701 36115 36134	the accumulation of
T15778	UBERON:0006585 36235 36246	cancer, and
T15779	UBERON:0000446 36481 36502	because the molecular
T15780	UBERON:4200184 36653 36668	efficacy of the
T15781	UBERON:0000310 36866 36872	breast
T15782	UBERON:0002393 37065 37068	who
T15783	UBERON:0000964 37473 37479	cancer
T15784	UBERON:0013731 38060 38068	estrogen
T15785	UBERON:0002828 38426 38428	of
T15786	UBERON:0005482 38614 38618	role
T15787	UBERON:0002630 38786 38792	growth
T15788	UBERON:0004180 42035 42050	mammary tissues
T15789	UBERON:2005078 42147 42152	dots,
T15790	UBERON:0003675 42364 42365	.
T15791	UBERON:0002531 42414 42422	end buds
T15792	UBERON:0001465 42635 42638	ko)
T15793	UBERON:0002484 42754 42765	elongation,
T15794	UBERON:0011631 42897 42908	like growth
T15795	UBERON:0001640 43165 43173	cells in
T15796	UBERON:0003675 43330 43331	.
T15797	UBERON:0001452 43380 43388	from the
T15798	UBERON:0002240 43560 43568	insulin-
T15799	UBERON:0001463 43847 43850	/ko
T15800	UBERON:0001270 43917 43928	staining of
